| # | Drug | Count |
|---|---|---|
| 0 | MONTELUKAST SODIUM | 117 |
| 1 | PREDNISONE | 99 |
| 2 | TIOTROPIUM BROMIDE | 92 |
| 3 | FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE | 84 |
| 4 | ALBUTEROL SULFATE | 79 |
| 5 | IPRATROPIUM BROMIDE | 74 |
| 6 | FUROSEMIDE | 69 |
| 7 | GLYCOPYRROLATE | 69 |
| 8 | FLUOXETINE HYDROCHLORIDE | 63 |
| 9 | THEOPHYLLINE ANHYDROUS | 62 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ZAFIRLUKAST | 19 | 0.0209 |
| 1 | DIBUCAINE 1% | 2 | 0.0174 |
| 2 | BETAMETHASONE VALERATE FOAM | 58 | 0.0126 |
| 3 | GLYCOPYRROLATE | 69 | 0.0122 |
| 4 | QUINAPRIL HYDROCHLORIDE | 61 | 0.0078 |
| 5 | NEOMYCIN SULFATE | 21 | 0.0077 |
| 6 | TOPICAL ANESTHETIC | 6 | 0.0074 |
| 7 | PREDNISOLONE SODIUM PHOSPHATE | 15 | 0.0060 |
| 8 | BENZOCAINE | 6 | 0.0060 |
| 9 | DIMENHYDRINATE | 60 | 0.0056 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 137 |
| 1 | Interleukin-5 Antagonist [EPC] | 100 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 70 |
| 3 | Loop Diuretic [EPC] | 69 |
| 4 | Insulin Analog [EPC] | 63 |
| 5 | Methylxanthine [EPC] | 62 |
| 6 | Osmotic Laxative [EPC] | 61 |
| 7 | Nitrate Vasodilator [EPC] | 58 |
| 8 | Nitrofuran Antibacterial [EPC] | 57 |
| 9 | Leukotriene Receptor Antagonist [EPC] | 55 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 100 | 0.1453 |
| 1 | Nitrofuran Antibacterial [EPC] | 57 | 0.0032 |
| 2 | beta Lactamase Inhibitor [EPC] | 9 | 0.0020 |
| 3 | Leukotriene Receptor Antagonist [EPC] | 55 | 0.0019 |
| 4 | Methylxanthine [EPC] | 62 | 0.0011 |
| 5 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 1 | 0.0009 |
| 6 | Nitrate Vasodilator [EPC] | 58 | 0.0007 |
| 7 | Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC] | 1 | 0.0006 |
| 8 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 9 | Parenteral Iron Replacement [EPC] | 5 | 0.0004 |